Pacific Biosciences' mission is to transform the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research.


We have developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. Combining recent advances in nanofabrication, biochemistry, molecular biology, surface chemistry and optics, Pacific Biosciences has created a powerful technology platform called single molecule, real-time (SMRT™) technology. SMRT technology enables real-time analysis of biomolecules with single molecule resolution, which has the potential to transform the understanding of biological systems by providing a window into these systems that has not previously been open for scientific study.

FEATURED Event

Events & Presentations

2017 JP Morgan Healthcare Conference

Jan 8, 2017
Westin St. Francis
San Francisco

Read More »

Pacific Biosciences of California, Inc. Conference Call

Dec 15, 2016

Read More »

Evercore ISI MedTools Conference

Nov 30, 2016
Boston, MA

Read More »

28th Annual Piper Jaffray Healthcare Conference

Nov 29, 2016
New York City, NY

Read More »

Recent News

Stock Quote

NASDAQ (GM): PACB
Price $4.55
Last Trade 4:00 PM ET
Jan 19, 2017
Change $0.00
Change (%) 0.000%
Volume N/A
52 Week High N/A
52 Week Low N/A
Day High N/A
Day Low N/A
Delayed at least 20 minutes.

Investor
Contact

Pacific Biosciences

1380 Willow Rd.

Menlo Park, Ca 94025

(650) 521-8450

ir@pacb.com